Granite FO’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Granite FO's NVO Position: Q3 2026 in Review
Granite FO held its Novo Nordisk (NVO) position steady in Q3 2026 at 590 shares worth $22.4K. The position accounts for 0.01% of the portfolio, ranked #88.
Granite FO first reported a position in NVO in Q4 2022 and has held it in 15 quarters since. The position peaked at $117K in Q3 2023. 1,061 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Granite FO held 590 shares of Novo Nordisk worth $22.4K as of Q3 2026.
- Granite FO left its Novo Nordisk share count unchanged in Q3 2026.
- Novo Nordisk made up 0.01% of Granite FO's portfolio in Q3 2026, its #88 holding.
- Granite FO first reported a position in Novo Nordisk in Q4 2022 and has held it in 15 quarters since.
- Granite FO's Novo Nordisk position peaked at $117K in Q3 2023.
- 1,061 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Granite FO's 13F filing for Q3 2026, filed 14 Oct 2026.